Takeda Pharmaceutical Company
-
Takeda launches Adynovate for haemophilia patients
An extended half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A, resulting in lower weekly infusion rates than standard FVIII,…
Read More » -
Serina Fischer joins Takeda as GM for India
Fischer will lead the company’s business in India, ensuring patient access to the company’s highly innovative medicines Takeda Pharmaceutical Company,…
Read More » -
Japan’s Takeda starts regulatory submissions for dengue vaccine in Europe
The European Medicines Agency would conduct an assessment of the vaccine, TAK-003 Japan’s Takeda Pharmaceutical Company had started regulatory submissions…
Read More » -
Takeda completes sale of select OTC and non-core assets to Hypera Pharma
The divestment agreement was first announced in March 2020 Takeda Pharmaceutical Company announced the completion of its previously-announced sale of…
Read More »
